Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Human Subject Protection Law Likely After “Building Block” Year – BIO

Executive Summary

BIO is preparing for legislative activity on human subject protection in the next Congress, Genentech Government Affairs Director Heidi Wagner told the Biotechnology Industry Organization annual meeting June 10 in Toronto

You may also be interested in...



Gregg Clinical Research Bill To Address Conflict Of Interest Without Caps

A bill to reform the human subject protection system under development by Sen. Judd Gregg (R-N.H.) will attempt to find a way to address potential conflict of interests without using caps on compensation

GOP Victories Spell Relief On Rx Pricing; Will State Budgets Cause Heartburn?

Burgeoning state healthcare costs are likely to take center stage on Capitol Hill during debates over drug pricing and Medicare pharmacy benefit legislation in the new year

GOP Victories Spell Relief On Rx Pricing; Will State Budgets Cause Heartburn?

Burgeoning state healthcare costs are likely to take center stage on Capitol Hill during debates over drug pricing and Medicare pharmacy benefit legislation in the new year

Related Content

UsernamePublicRestriction

Register

PS040051

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel